Abstract
Low-density lipoprotein (LDL) provides a highly versatile natural nanoplatform for delivery of optical and MRI contrast agents, photodynamic therapy agents and chemotherapeutic agents to normal and neoplastic cells that over express LDL receptors (LDLR). Extension to other lipoproteins ranging in diameter from ~5-10 nm (high density lipoprotein, HDL) to over a micron (chilomicrons) is feasible. Loading of contrast or therapeutic agents has been achieved by covalent attachment to protein side chains, intercalation into the phospholipid monolayer and extraction and reconstitution of the triglyceride/cholesterol ester core. Covalent attachment of folate to the lysine side chain amino groups was used to reroute the LDL from its natural receptor (LDLR) to folate receptors and could be utilized to target other receptors. A semi-synthetic nanoparticle has been constructed by coating magnetite iron oxide nanoparticles (MIONs) with carboxylated cholesterol and overlaying a monolayer of phospholipid to which Apo A1, Apo E or synthetic amphoteric 〈-helical polypeptides were adsorbed for targeting HDL, LDL or folate receptors, respectively. These particles can be utilized for in situloading of magnetite into cells for MRI monitored cell tracking or gene therapy.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
D. E. Vance and J. E. Vance. Biochemistry of Lipids, Lipoproteins and Membranes (Elsevier Science, Amsterdam, 2002).
J. M. Shaw. Lipoproteins as Carriers of Pharmacological Agents (Marcel Dekker, New York, 1991).
G. Zheng, J. Chen, H. Li and J. D. Glickson. Rerouting lipoprotein nanoparticles to selected alternate receptors for the targeted delivery of cancer diagnostic and therapeutic agents. Proceedings of the National Academy of Sciences of the United States of America 102, 17757-17762 (2005).
H. Li, Z. H. Zhang, D. Blessington, D. S. Nelson, R. Zhou, S. Lund-Katz, B. Chance, J. D. Glickson and G. Zheng. Carbocyanine labeled LDL for optical Imaging of tumors. Academic Radiology 11, 669-677 (2004).
G. Zheng, H. Li, M. Zhang, S. Lund-Katz, B. Chance and J. D. Glickson. Low-density lipoprotein reconstituted by pyropheophorbide cholesteryl oleate as target-specific photosensitizer. Bioconjugate Chemistry 13, 392-396 (2002).
I. R. Corbin, H. Li, J. Chen, S. Lund-Katz, R. Zhou, J. D. Glickson and G. Zheng. Low-density lipoprotein nanoparticles as magnetic resonance imaging contrast agents. Neoplasia 8, 488-498 (2006).
R. A. Firestone. Low density lipoprotein as a vehicle for targeting antitumor compounds to cancer cells. Bioconjugate Chem. 5, 105-113 (1994).
P. C. de Smidt and T. J. C. van Berkel. Prolonged serum half-life of antineoplastic drugs by incorportation into the low density lipoprotein. Cancer Res. 50, 7476-82 (1990).
P. C. N. Rensen, R. M. Schiffelers, J. Versluis, M. K. Bijsterbosch, M. E. M. J. van Kuijk-Meuwissen and T. J. C. van Berkel. Human recombinant apolipoprotein E-enriched liposomes can mimic low-density lipoproteins as carriers for the site-specific delivery of antitumor agents. Molec. Pharmacol. 52, 445-455 (1997).
S. M. Moerlein, A. Daugherty, B. E. Sobel and M. J. Welch. Metabolic Imaging with Gallium-68-Labeled and Indium-111-Labeled Low-Density-Lipoprotein. Journal of Nuclear Medicine 32, 300-307 (1991).
E. Ponty, G. Favre, R. Benaniba, A. Boneu, H. Lucot, M. Carton and G. Soula. Biodistribution Study of Tc-99m-Labeled LDL in B16-Melanoma-Bearing Mice - Visualization of a Preferential Uptake by the Tumor. International Journal of Cancer 54, 411-417 (1993).
J. Pietzsch, R. Bergmann, K. Rode, C. Hultsch, B. Pawelke, F. Wuest and J. van den Hoff. Fluorine-18 radiolabeling of low-density lipoproteins: a potential approach for characterization and differentiation of metabolism of native and oxidized low-density lipoproteins in vivo. Nuclear Medicine and Biology 31, 1043-1050 (2004).
G. Sobal, U. Resch and H. Sinzinger. Modification of low-density lipoprotein by different radioiodination methods. Nuclear Medicine and Biology 31, 381-388 (2004).
M. Krieger, M. S. Brown, J. R. Faust and J. L. Goldstein. Replacement of endogenous cholesteryl esters of low density lipoprotein with exogenous cholesteryl linoleate. Reconstitution of a biologically active lipoprotein particle. Journal of Biological Chemistry 253, 4093-101 (1978).
M. Krieger, Y. K. Ho and J. R. Falck. Reconstitution of LDL with lipophilic fluorescein derivatives: Quantitative analysis of the receptor activity of human lymphocytes. J. Receptor Res. 3, 361-75 (1983).
G. Zheng, H. Li, K. Yang, D. Blessington, K. Licha, S. Lund-Katz, B. Chance and J. D. Glickson. Tricarbocyanine cholesteryl laurates labeled LDL: New near infrared fluorescent probes (NIRFs) for monitoring tumors and gene therapy of Familial hypercholesterolemia. Bioorganic & Medicinal Chemistry Letters 12, 1485-1488 (2002).
S. P. Wu, I. Lee, P. P. Ghoroghchian, P. R. Frail, G. Zheng, J. D. Glickson and M. J. Therien. Nearinfrared optical Imaging of B16 melanoma cells via low-density lipoprotein-mediated uptake and delivery of high emission dipole strength tris[(porphinato)zinc(II)] fluorophores. Bioconjugate Chemistry 16, 542- 550 (2005).
B. Quistorff, J. C. Haselgrove and B. Chance. High resolution readout of 3-D metabolic organ structure: An automated, low-temperature redox ratio-scanning instrument. Anal. Biochem. 148, 389-400 (1985).
S. Lund-Katz, J. A. Ibdah, J. Y. Letizia, M. T. Thomas and M. C. Phillips. A 13C NMR characterization of lysine residues in apolipoprotein B and their role in binding to the low density lipoprotein receptor. Journal of Biological Chemistry 263, 13831-8 (1988).
J. Chen, I. R. Corbin, H. Li, W. G. Cao, J. D. Glickson and G. Zheng. Ligand conjugated low-density lipoprotein nanoparticles for enhanced optical cancer imaging in vivo. Journal of the American Chemical Society 129, 5798- (2007).
J. W. M. Bulte, A. S. Arbab, T. Douglas and J. A. Frank. in Imaging in Biological Research, Pt B 275-299 (2004).
K. A. Hinds, J. M. Hill, E. M. Shapiro, M. O. Laukkanen, A. C. Silva, C. A. Combs, T. R. Varney, R. S. Balaban, A. P. Koretsky and C. E. Dunbar. Highly efficient endosomal labeling of progenitor and stem cells with large magnetic particles allows magnetic resonance imaging of single cells. Blood 102, 867-872 (2003).
J. W. M. Bulte, I. D. Duncan and J. A. Frank. In vivo magnetic resonance tracking of magnetically labeled cells after transplantation. Journal of Cerebral Blood Flow and Metabolism 22, 899-907 (2002).
R. Weissleder and U. Mahmood. Molecular imaging. Radiology 219, 316-333 (2001).
R. Weissleder, A. Bogdanov, E. A. Neuwelt and M. Papisov. Long-circulating iron-oxides for MRimaging. Advanced Drug Delivery Reviews 16, 321-334 (1995).
H. Choi, S. R. Choi, R. Zhou, H. F. Kung and I. W. Chen. Iron oxide nanoparticles as magnetic resonance contrast agent for tumor imaging via folate receptor-targeted delivery. Academic Radiology 11, 996-1004 (2004).
M. Navab, G. M. Anantharamaiah, S. T. Reddy, S. Hama, G. Hough, V. R. Grijalva, N. Yu, B. J. Ansell, G. Datta, D. W. Garber and A. M. Fogelman. Apolipoprotein A-I mimetic peptides. Arteriosclerosis Thrombosis and Vascular Biology 25, 1325-1331 (2005).
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer Science+Business Media, LLC
About this paper
Cite this paper
Glickson, J.D. et al. (2009). Lipoprotein Nanoplatform for Targeted Delivery of Diagnostic and Therapeutic Agents. In: Liss, P., Hansell, P., Bruley, D.F., Harrison, D.K. (eds) Oxygen Transport to Tissue XXX. Advances in Experimental Medicine and Biology, vol 645. Springer, Boston, MA. https://doi.org/10.1007/978-0-387-85998-9_35
Download citation
DOI: https://doi.org/10.1007/978-0-387-85998-9_35
Publisher Name: Springer, Boston, MA
Print ISBN: 978-0-387-85997-2
Online ISBN: 978-0-387-85998-9
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)